Kazuhisa Z. Takahashi
Advanced in Mycobacterium Avium Complex Infections

Kazuhisa Z. Takahashi

Hongo, JP 
Advanced in Mycobacterium Avium Complex Infections
Hongo, JP 
OverviewLocationsClinical Research

Overview

Kazuhisa Takahashi practices in Hongo, Japan. Takahashi is rated as an Advanced expert by MediFind in the treatment of Mycobacterium Avium Complex Infections. Their top areas of expertise are Lymphangioleiomyomatosis, Lung Cancer, Birt-Hogg-Dube Syndrome, Spinal Fusion, and Osteotomy.

Their clinical research consists of co-authoring 879 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 4 articles in the study of Mycobacterium Avium Complex Infections.

Locations

Hongo, 1138421, Japan
Other Locations
Tokyo, Japan
Kashiwa, Japan
Kitano, Japan
Japan
Hirakata, Japan
Bunkyo, Japan
Osaka, Japan
Okazaki, Japan
Tsukuba, 3058568, Japan
Kyoto, Japan
Tottori, Japan
Nankoku, 7838509, Japan
Chiba, Japan
Hirosaki, Japan
Anjo, Japan
Yokohama, Japan
Nagaoka, 9402188, Japan
Kawasaki, 2120013, Japan
Sendai, 9808578, Japan
Chuo, 2600856, Japan
Chuo, 2608670, Japan
Nagoya, Japan
Koshigaya, Japan
Nagasaki, Japan
Suita, 5650871, Japan
Niigata, Japan
Asahi, 5458585, Japan
Sugimoto, 5588585, Japan
Otsu, Japan
Izunokuni, 4102295, Japan
Shimonagakubo, 4118777, Japan
Maebashi, Japan
Sagamihara, Japan
Kanagawa, Japan
Fukuoka, Japan
Toyama, Japan
Hiroshima, Japan
Matsudo, Japan
Meguro, 1538902, Japan
Kanazawa, 9201192, Japan
Tochigi, Japan
Murakami, 2608670, Japan
Nigata-honmachi, Japan
Senboku, Japan
Maizuru Fisheries Research Station, Nagahama, Maizuru, 6250086, Japan
Shimotsuke, Japan
Naka, 3110193, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

LIBRETTO-432: A Placebo-controlled Double-Blinded Randomized Phase 3 Study of Adjuvant Selpercatinib Following Definitive Locoregional Treatment in Participants With Stage IB-IIIA RET Fusion-Positive NSCLC
LIBRETTO-432: A Placebo-controlled Double-Blinded Randomized Phase 3 Study of Adjuvant Selpercatinib Following Definitive Locoregional Treatment in Participants With Stage IB-IIIA RET Fusion-Positive NSCLC
Enrollment Status: Active_not_recruiting
Publish Date: July 24, 2025
Intervention Type: Drug
Study Drug: Selpercatinib
Study Phase: Phase 3

879 Total Publications

BRAF V600E-Mutant Diffuse Pulmonary Langerhans Cell Histiocytosis Successfully Treated With Dabrafenib Plus Trametinib: A Case Report.
BRAF V600E-Mutant Diffuse Pulmonary Langerhans Cell Histiocytosis Successfully Treated With Dabrafenib Plus Trametinib: A Case Report.
Journal: Respirology case reports
Published: August 12, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Takahashi's expertise for a condition
ConditionClose
View All 7 Elite Conditions
View All 13 Distinguished Conditions
View All 36 Advanced Conditions
View All 157 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile